165 related articles for article (PubMed ID: 32736515)
1. MutEnricher: a flexible toolset for somatic mutation enrichment analysis of tumor whole genomes.
Soltis AR; Dalgard CL; Pollard HB; Wilkerson MD
BMC Bioinformatics; 2020 Jul; 21(1):338. PubMed ID: 32736515
[TBL] [Abstract][Full Text] [Related]
2. Whole-genome sequencing with long reads reveals complex structure and origin of structural variation in human genetic variations and somatic mutations in cancer.
Fujimoto A; Wong JH; Yoshii Y; Akiyama S; Tanaka A; Yagi H; Shigemizu D; Nakagawa H; Mizokami M; Shimada M
Genome Med; 2021 Apr; 13(1):65. PubMed ID: 33910608
[TBL] [Abstract][Full Text] [Related]
3. NIMBus: a negative binomial regression based Integrative Method for mutation Burden Analysis.
Zhang J; Liu J; McGillivray P; Yi C; Lochovsky L; Lee D; Gerstein M
BMC Bioinformatics; 2020 Oct; 21(1):474. PubMed ID: 33092526
[TBL] [Abstract][Full Text] [Related]
4. Cancer regulatory variation.
Hennessey RC; Brown KM
Curr Opin Genet Dev; 2021 Feb; 66():41-49. PubMed ID: 33422949
[TBL] [Abstract][Full Text] [Related]
5. Beyond the exome: the role of non-coding somatic mutations in cancer.
Piraino SW; Furney SJ
Ann Oncol; 2016 Feb; 27(2):240-8. PubMed ID: 26598542
[TBL] [Abstract][Full Text] [Related]
6. Whole genome sequencing analysis for cancer genomics and precision medicine.
Nakagawa H; Fujita M
Cancer Sci; 2018 Mar; 109(3):513-522. PubMed ID: 29345757
[TBL] [Abstract][Full Text] [Related]
7. Identification of coding and non-coding mutational hotspots in cancer genomes.
Piraino SW; Furney SJ
BMC Genomics; 2017 Jan; 18(1):17. PubMed ID: 28056774
[TBL] [Abstract][Full Text] [Related]
8. Cancer whole-genome sequencing: present and future.
Nakagawa H; Wardell CP; Furuta M; Taniguchi H; Fujimoto A
Oncogene; 2015 Dec; 34(49):5943-50. PubMed ID: 25823020
[TBL] [Abstract][Full Text] [Related]
9. pyCancerSig: subclassifying human cancer with comprehensive single nucleotide, structural and microsatellite mutational signature deconstruction from whole genome sequencing.
Thutkawkorapin J; Eisfeldt J; Tham E; Nilsson D
BMC Bioinformatics; 2020 Apr; 21(1):128. PubMed ID: 32245405
[TBL] [Abstract][Full Text] [Related]
10. A Dual Model for Prioritizing Cancer Mutations in the Non-coding Genome Based on Germline and Somatic Events.
Li J; Poursat MA; Drubay D; Motz A; Saci Z; Morillon A; Michiels S; Gautheret D
PLoS Comput Biol; 2015 Nov; 11(11):e1004583. PubMed ID: 26588488
[TBL] [Abstract][Full Text] [Related]
11. MutSpec: a Galaxy toolbox for streamlined analyses of somatic mutation spectra in human and mouse cancer genomes.
Ardin M; Cahais V; Castells X; Bouaoun L; Byrnes G; Herceg Z; Zavadil J; Olivier M
BMC Bioinformatics; 2016 Apr; 17():170. PubMed ID: 27091472
[TBL] [Abstract][Full Text] [Related]
12. Discovery of potential causative mutations in human coding and noncoding genome with the interactive software BasePlayer.
Katainen R; Donner I; Cajuso T; Kaasinen E; Palin K; Mäkinen V; Aaltonen LA; Pitkänen E
Nat Protoc; 2018 Nov; 13(11):2580-2600. PubMed ID: 30323186
[TBL] [Abstract][Full Text] [Related]
13. Systematic Screening of Promoter Regions Pinpoints Functional Cis-Regulatory Mutations in a Cutaneous Melanoma Genome.
Poulos RC; Thoms JA; Shah A; Beck D; Pimanda JE; Wong JW
Mol Cancer Res; 2015 Aug; 13(8):1218-26. PubMed ID: 26082173
[TBL] [Abstract][Full Text] [Related]
14. CScape-somatic: distinguishing driver and passenger point mutations in the cancer genome.
Rogers MF; Gaunt TR; Campbell C
Bioinformatics; 2020 Jun; 36(12):3637-3644. PubMed ID: 32282885
[TBL] [Abstract][Full Text] [Related]
15. Combined burden and functional impact tests for cancer driver discovery using DriverPower.
Shuai S; ; Gallinger S; Stein LD;
Nat Commun; 2020 Feb; 11(1):734. PubMed ID: 32024818
[TBL] [Abstract][Full Text] [Related]
16. Personal Cancer Genome Reporter: variant interpretation report for precision oncology.
Nakken S; Fournous G; Vodák D; Aasheim LB; Myklebost O; Hovig E
Bioinformatics; 2018 May; 34(10):1778-1780. PubMed ID: 29272339
[TBL] [Abstract][Full Text] [Related]
17. Whole-genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genes.
Sakthikumar S; Roy A; Haseeb L; Pettersson ME; Sundström E; Marinescu VD; Lindblad-Toh K; Forsberg-Nilsson K
Genome Biol; 2020 Jun; 21(1):127. PubMed ID: 32513296
[TBL] [Abstract][Full Text] [Related]
18. Cis-regulatory somatic mutations and gene-expression alteration in B-cell lymphomas.
Mathelier A; Lefebvre C; Zhang AW; Arenillas DJ; Ding J; Wasserman WW; Shah SP
Genome Biol; 2015 Apr; 16(1):84. PubMed ID: 25903198
[TBL] [Abstract][Full Text] [Related]
19. OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations.
Mularoni L; Sabarinathan R; Deu-Pons J; Gonzalez-Perez A; López-Bigas N
Genome Biol; 2016 Jun; 17(1):128. PubMed ID: 27311963
[TBL] [Abstract][Full Text] [Related]
20. FIREVAT: finding reliable variants without artifacts in human cancer samples using etiologically relevant mutational signatures.
Kim H; Lee AJ; Lee J; Chun H; Ju YS; Hong D
Genome Med; 2019 Dec; 11(1):81. PubMed ID: 31847917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
